The residual cancer burden index as a valid prognostic indicator in breast cancer after neoadjuvant chemotherapy
Article in BMC Cancer (January 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Risk factors of breast cancer recurrence in pathologic complete response achieved by patients following neoadjuvant chemotherapy: a single-center retrospective study
Article in Frontiers in Oncology (October 2023)
End-of-neoadjuvant treatment circulating microRNAs and HER2-positive breast cancer patient prognosis: An exploratory analysis from NeoALTTO
Article in Frontiers in Oncology (January 2023)